Vistin Pharma ASA: Invitation to Q2 2025 conference call

Oslo, Norway, 08 August 2025

Vistin Pharma ASA will release its second quarter and YTD 2025 results on Friday 15th of August 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The second quarter conference call will be available via web and audio through the following access points:

Webcast:
https://edge.media-server.com/mmc/p/vvot47w4

Telephone conference (online registration):
https://register-conf.media-server.com/register/BI65266ce5abba480f9cda4180274c996b

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
[email protected]

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

You May Also Be Interested In

• Crypto News: Pepeto Announces Its Full DeFi Toolkit While Bitcoin Price Prediction Points to $200,000
• Bectran Named to Construction Executive's 2026 Top Tech™ List for Fifth Consecutive Year
• Wish Granted: Notable Investors Join Social Shopping Platform GoWish With Double-Digit Million Euro Investment